Antonio Giovanni Richetta

9PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological methodsDiagnostic radiographyPodiatryImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage.

|Jul 27, 2026
Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio Region.

|Mar 27, 2026
Psoriasis in Difficult-to-Treat Areas: A Multicentre, Real-World Retrospective Study Analyzing the Impact of Non-Invasive Imaging Techniques (Dermoscopy, Reflectance Confocal Microscopy and Optical Coherence Tomography) to Monitor the Effectiveness of Risankizumab in the Treatment of Plaque Psoriasis of the Legs.

Annunziata Dattola, Raimondo Rossi, Giuseppe Rizzuto

|Jan 11, 2025
Tildrakizumab and Quality of Life: Deep Dive into the Impact of Psoriasis and Treatment on Different Domains-Should Psychosocial Life Impairment Be Considered a Comorbidity?

Gaetano Licata, Eugenia Veronica Di Brizzi, Franco Castelli

|Dec 27, 2024
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.

Nicoletta Bernardini, Annunziata Dattola, Raimondo Rossi

|Oct 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak

Pageof 2

Frequent Collaborators

6 joint publications

Annunziata Dattola

5 joint publications

Nicoletta Bernardini

3 joint publications

Nevena Skroza

2 joint publications

Francesca Prignano